WitrynaAIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of … WitrynaAfter Hours trades will be posted from 4:15 p.m. ET to 3:30 p.m. ET of the following day. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data ...
AIM ImmunoTech Inc. (AIM) Stock Historical Prices & Data - Yahoo!
WitrynaAbout AIM ImmunoTech Inc. AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular ... Read more. Name AIM ImmunoTech Inc. Witryna27 mar 2024 · AIM ImmunoTech Inc (AIM) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... AIM ImmunoTech Inc lowest stock price was $0.29 and its highest was $1.38 in the past 12 months. What is AIM ImmunoTech Inc’s market … leukemia in 20s
Current Report Filing (8-k)
Witryna30 wrz 2024 · AIM ImmunoTech Inc (NYSE: AIM) has signed a Clinical Trial Agreement with hVIVO for Phase 2a Human Challenge Trial (HCT) for intranasal Ampligen as prophylaxis against respiratory viruses. The HCT ... Witryna2 kwi 2013 · The growth of a stock is directly proportional to the capital gains one will achieve by holding a stock. The percentage growth of a stock is a key metric for investment decisions. Let us compare the growth of Aim Immunotech Inc and Silver Trust Ishares stocks over 1-year, 3-year, 5-year and 10-year periods. Table1: Growth … WitrynaThe 52-week low for AIM stock is $0.29. The current AIM stock price $0.4099 has increased 29.01% from its 52-week low. awo kita dolli einstein